WGU D116 Advanced Pharmacology Study Guide-
Practice Questions & Rationale Frameworks 2026-
2027
This comprehensive study resource features targeted practice assessments and
detailed rationale breakdowns designed specifically for Western Governors University’s
advanced pharmacology curriculum. It emphasizes complex pharmacokinetic profiles,
advanced pharmacodynamics, and individualized prescriptive authority reasoning
across diverse patient lifespans. Nursing students will build the diagnostic confidence
required to successfully master the objective assessment and safely prescribe in
advanced practice settings.
Question 1
Which process describes the movement of a drug from its site of administration into the
systemic circulation?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Rationale: Absorption is the transfer of a medication from its administration site into the
bloodstream, where it becomes available for distribution to tissues .
Question 2
Which pharmacokinetic characteristic most directly determines how much of an
administered dose reaches systemic circulation unchanged?
A. Bioavailability
B. Potency
C. Efficacy
D. Therapeutic index
,Rationale: Bioavailability represents the fraction of an administered drug dose that
reaches systemic circulation in active form .
Question 3
Why does oral administration commonly result in lower bioavailability than intravenous
administration?
A. Oral drugs are never completely absorbed.
B. Oral drugs may undergo intestinal and hepatic first-pass metabolism before
reaching systemic circulation.
C. Intravenous drugs undergo greater first-pass metabolism.
D. Oral drugs bypass the liver entirely.
Rationale: Drugs absorbed from the gastrointestinal tract commonly pass through the
portal circulation and liver before reaching systemic circulation, allowing presystemic
metabolism to reduce available drug .
Question 4
Which pharmacokinetic phase involves reversible movement of medication from the
bloodstream into tissues?
A. Absorption
B. Distribution
C. Biotransformation
D. Elimination
Rationale: Distribution describes the movement of drug molecules between the
bloodstream and body tissues after absorption .
Question 5
,A medication strongly inhibits CYP3A4. What effect can occur when it is given with
another drug primarily metabolized by CYP3A4?
A. The second drug is absorbed more slowly but cleared faster.
B. The second drug is converted immediately into an inactive compound.
C. Renal filtration of the second drug increases.
D. Plasma concentrations of the second drug may rise because its metabolism
decreases.
Rationale: Enzyme inhibition reduces metabolism of susceptible substrates and can
increase their plasma concentrations and toxicity risk .
Question 6
What is the most likely effect of a strong hepatic enzyme inducer on a drug metabolized
by that enzyme?
A. Decreased drug concentration because metabolism accelerates
B. Increased drug concentration because elimination stops
C. Elimination of first-pass metabolism
D. Increased receptor sensitivity
Rationale: Enzyme induction increases metabolic activity and may decrease concentrations
and therapeutic effects of drugs metabolized by the induced pathway .
Question 7
Which laboratory value requires immediate action in a patient taking spironolactone?
A. Sodium 135 mEq/L
B. Potassium 5.9 mEq/L
C. Chloride 100 mEq/L
D. Glucose 95 mg/dL
Rationale: Spironolactone is potassium-sparing; potassium >5.5 mEq/L increases risk of
life-threatening arrhythmias .
, Question 8
A patient newly started on lisinopril develops a persistent dry cough. What is the
mechanism?
A. Histamine release from mast cells
B. Bradykinin accumulation in the airways
C. Direct bronchial smooth muscle constriction
D. Leukotriene overproduction
Rationale: ACE inhibitors prevent bradykinin breakdown, leading to bradykinin
accumulation, which causes dry cough .
Question 9
A patient on warfarin presents with an INR of 1.1. The patient reports starting a new
herb. Which herb is most likely?
A. Garlic
B. Ginkgo biloba
C. St. John's wort
D. Ginger
Rationale: St. John's wort induces CYP2C9 and CYP3A4, reducing warfarin levels and INR .
Question 10
A patient on metformin reports muscle pain and fatigue. What is the most serious
concern?
A. Hypoglycemia
B. Lactic acidosis
C. Vitamin B12 deficiency
D. Weight gain
Practice Questions & Rationale Frameworks 2026-
2027
This comprehensive study resource features targeted practice assessments and
detailed rationale breakdowns designed specifically for Western Governors University’s
advanced pharmacology curriculum. It emphasizes complex pharmacokinetic profiles,
advanced pharmacodynamics, and individualized prescriptive authority reasoning
across diverse patient lifespans. Nursing students will build the diagnostic confidence
required to successfully master the objective assessment and safely prescribe in
advanced practice settings.
Question 1
Which process describes the movement of a drug from its site of administration into the
systemic circulation?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Rationale: Absorption is the transfer of a medication from its administration site into the
bloodstream, where it becomes available for distribution to tissues .
Question 2
Which pharmacokinetic characteristic most directly determines how much of an
administered dose reaches systemic circulation unchanged?
A. Bioavailability
B. Potency
C. Efficacy
D. Therapeutic index
,Rationale: Bioavailability represents the fraction of an administered drug dose that
reaches systemic circulation in active form .
Question 3
Why does oral administration commonly result in lower bioavailability than intravenous
administration?
A. Oral drugs are never completely absorbed.
B. Oral drugs may undergo intestinal and hepatic first-pass metabolism before
reaching systemic circulation.
C. Intravenous drugs undergo greater first-pass metabolism.
D. Oral drugs bypass the liver entirely.
Rationale: Drugs absorbed from the gastrointestinal tract commonly pass through the
portal circulation and liver before reaching systemic circulation, allowing presystemic
metabolism to reduce available drug .
Question 4
Which pharmacokinetic phase involves reversible movement of medication from the
bloodstream into tissues?
A. Absorption
B. Distribution
C. Biotransformation
D. Elimination
Rationale: Distribution describes the movement of drug molecules between the
bloodstream and body tissues after absorption .
Question 5
,A medication strongly inhibits CYP3A4. What effect can occur when it is given with
another drug primarily metabolized by CYP3A4?
A. The second drug is absorbed more slowly but cleared faster.
B. The second drug is converted immediately into an inactive compound.
C. Renal filtration of the second drug increases.
D. Plasma concentrations of the second drug may rise because its metabolism
decreases.
Rationale: Enzyme inhibition reduces metabolism of susceptible substrates and can
increase their plasma concentrations and toxicity risk .
Question 6
What is the most likely effect of a strong hepatic enzyme inducer on a drug metabolized
by that enzyme?
A. Decreased drug concentration because metabolism accelerates
B. Increased drug concentration because elimination stops
C. Elimination of first-pass metabolism
D. Increased receptor sensitivity
Rationale: Enzyme induction increases metabolic activity and may decrease concentrations
and therapeutic effects of drugs metabolized by the induced pathway .
Question 7
Which laboratory value requires immediate action in a patient taking spironolactone?
A. Sodium 135 mEq/L
B. Potassium 5.9 mEq/L
C. Chloride 100 mEq/L
D. Glucose 95 mg/dL
Rationale: Spironolactone is potassium-sparing; potassium >5.5 mEq/L increases risk of
life-threatening arrhythmias .
, Question 8
A patient newly started on lisinopril develops a persistent dry cough. What is the
mechanism?
A. Histamine release from mast cells
B. Bradykinin accumulation in the airways
C. Direct bronchial smooth muscle constriction
D. Leukotriene overproduction
Rationale: ACE inhibitors prevent bradykinin breakdown, leading to bradykinin
accumulation, which causes dry cough .
Question 9
A patient on warfarin presents with an INR of 1.1. The patient reports starting a new
herb. Which herb is most likely?
A. Garlic
B. Ginkgo biloba
C. St. John's wort
D. Ginger
Rationale: St. John's wort induces CYP2C9 and CYP3A4, reducing warfarin levels and INR .
Question 10
A patient on metformin reports muscle pain and fatigue. What is the most serious
concern?
A. Hypoglycemia
B. Lactic acidosis
C. Vitamin B12 deficiency
D. Weight gain
